This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...

Bupropion Hydrochloride Extended-Release Tablets USP (SR) are bioequivalent and therapeutically equivalent to Wellbutrin SR ...

Exclusive: One in three researchers say their peers force them to carry out tests with animals if their work is to be ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

With the appointment of Christian Tucat as CEO, Sciensus aims to leverage insights and expand its global reach in delivering lifesaving drugs and therapies.

The global malaria treatment market is projected to be valued at approximately USD 1.8 billion in the fiscal year 2023, an ...

The job sector in the United Kingdom provides numerous chances for international workers, particularly via the UK Work Visa. According to Last Stop Booking, the average monthly income for positions in ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

The abbreviated new drug application (ANDA) for the product was filed with the USFDA by Granules Pharmaceuticals, Inc. (GPI), ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...